Induced expression of drug metabolizing enzymes by preventive agents: Role of the antioxidant response element

Chemico-Biological Interactions

Volumn 182, Issue 1, 2009, Pages 22-28

  Lubet, Ronald A ^a   Yao, Ruisheng ^b   Grubbs, Clinton J ^c   You, Ming ^b   Wang, Yian ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b USA   (United States)

^c Kentucky   (United States)

Author keywords

Antioxidant response element; Chemopreventive agents; Phase I II inducers

Indexed keywords

ALDEHYDE KETO REDUCTASE; ALLYL SULFIDE; BETA NAPHTHOFLAVONE; CELL NUCLEUS RECEPTOR; CYCLOPENTADITHIOLTHIONE; DITHIOTHREITOL; DRUG METABOLIZING ENZYME; ETHOXYQUIN; GLUTATHIONE TRANSFERASE; ORGANOSULFUR DERIVATIVE; OXIDOREDUCTASE; PHENOBARBITAL; RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CONTROLLED STUDY; DIET; DNA MICROARRAY; FEEDING; FEMALE; GENE AMPLIFICATION; GENE CLUSTER; GENE EXPRESSION; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; RNA ISOLATION;

ALLYL COMPOUNDS; ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; BETA-NAPHTHOFLAVONE; ENZYME INDUCTION; ETHOXYQUIN; FEMALE; GENE EXPRESSION REGULATION; GLUTATHIONE TRANSFERASE; LIVER; NAD(P)H DEHYDROGENASE (QUINONE); OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFHYDRYL COMPOUNDS; SULFIDES; THIONES; THIOPHENES;

RATTUS;

EID: 70349627876     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.08.011     Document Type: Article

References (37)

1. Miller J.A. Carcinogenesis by chemicals: an overview-GHA Clowes Memorial Lecture. Cancer Res. 30 (1970) 559-576
2. Miller E.C., Miller J.A., Brown R.R., and MacDonald J.C. On the protective action of certain polycyclic aromatic hydrocarbons against carcinogenesis by aminoazo dyes and 2-acetylaminofluorene. Cancer Res. 18 (1958) 469-478
3. Wattenberg L.W. Chemoprevention of cancer. Cancer Res. 45 (1985) 1-8
4. Sporn M.B. Retinoids and cancer prevention. Carcinog. Compr. Surv. 5 (1980) 99-109
5. Fisher B., Costantino J.P., Wickerham D.L., Redmond C.K., Kavana H.M., Cronin W.M., Vogel V., Robidoux A., Dimitron N., Atkins J., Daly M., Wieand S., Tan-Chiu E., Ford L., and Wolmark N. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. 90 (1998) 371-388
6. Bertagnolli M.M., Eagle C.J., Zauber A.G., Redstone M., Solomon S.D., Kim K., Tang J., Rosenstein R.B., Wittes J., Corle D., Hess T.M., Woloj G.M., Boisserie F., Anderson W.F., Viner J.L., Bagheri D., Burns J., Chung D.C., Drewar T., Foley T.R., Hoffman N., Macrae F., Pruitt R.E., Saltzman J.R., Salzberg B., Sylwestrowicz T., Gordon G.B., Hawk E.T., and APC Study Investigators. Celecoxib for the prevention of sporadic colorectal adenomas. N. Engl. J. Med. 355 (2006) 873-884
7. Wattenberg L.W. Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic antioxidants and ethyoxquin. J. Natl. Cancer Inst. 48 (1972) 1425-1430
8. Parkinson A., and Hurwitz A. Omeprazole and the induction of human cytochrome P450: a reponse to concerns about potential adverse effects. Gastroenterology 100 (1991) 1157-1167
9. Talalay P., Dinkova-Kostova A.T., and Holtzeclaw W.D. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv. Enzyme Regul. 43 (2003) 121-134
10. DeLong M.J., Prochaska H.J., and Talalay P. Induction of NAD(P)H: quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes and other chemoprotectors: a model system for the study of anticarcinogens. Proc. Natl. Acad. Sci. USA 83 (1986) 787-791
11. Fahey J.W., Dinkova-Kostova A.T., Stephenson K.K., and Talalay P. The "Procahska" microtiter plate bioassay for inducers of NQO1. Methods Enzymol. 382 (2004) 243-258
12. Dinkova-Kostova A.T., Fahey J.W., and Talalay P. Chemical structures of inducers of nicotinamide quinone oxidoreductase (NQO1). Methods Enzymol. 382 (2004) 423-448
13. Nguyen T., Sherratt P.J., and Pickett C.B. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 233-260
14. Nguyen T., Sherratt P.J., Nioi P., Yang C.S., and Pickett C.B. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J. Biol. Chem. 280 (2005) 32485-32492
15. Jeong W.S., Jun M., and Kong A.N. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid. Redox Signal. 8 (2006) 99-106
16. Buetler T.M., Gallagher E.P., Wang C., Stahl D.L., Hayes J.D., and Eaton D.L. Induction of Phase I and Phase II drug-metabolizing enzyme mRNA protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicol. Appl. Pharmacol. 135 (1995) 1067-1078
17. Lubet R.A., Dragnev K.H., Chauhan D.P., Nims R.W., Diwan B.A., Ward J.M., Jones C.R., Rice J.M., and Miller M.S. A pleiotropic response to phenobarbital-type enzyme inducers in the F344/NCr rat. Effects of chemicals of varied structure. Biochem. Pharmacol. 43 (1992) 1067-1078
18. Roebuck B.D., Curphey T.J., Li Y., Baumgartner K.J., Bodreddigari S., Yan J., Gange S.J., Kensler T.W., and Sutter T.R. Evaluation of cancer chemopreventive potency of dithiolthione analogs of oltipraz. Carcinogenesis 24 (2003) 1919-1928
19. Wang Y., Yao R., Maciag A., Grubbs C.J., Lubet R.A., and You M. Organ specific expression profiles of rat mammary gland, liver and lung tissues treated with targretin, 9-cis-retinoic acid and 4-hydroxyphenylretinamide. Mol. Cancer Ther. 5 (2006) 1060-1072
20. Chiang D.Y., Brown P.O., and Eisen M.B. Visualizing associations between genome sequences and gene expression data using genome mean expression profiles. Bioinformatics 17 (2001) S49-55
21. Habel L.A., Bull S.A., and Friedman G.D. Barbiturates, smoking, and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 1049-1050
22. Watson A.J., and Hankinson O. Dioxin-and Ah receptor-dependent protein binding to xenobiotic resposive elements and G-rich DNA studies by in vivo foot printing. J. Biol. Chem. 267 (1992) 6874-6878
23. Sueyoshi T., and Negishi M. Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 123-143
24. Timsit Y., and Negishi M. CAR and PXR: the xenobiotic sensing receptors. Steroids 72 (2007) 231-246
25. Dragnev K.H., Nims R.W., and Lubet R.A. The chemopreventive agent diallyl sulfide. A structurally atypical phenobarbital-type inducer. Biochem. Pharmacol. 50 (1995) 2099-2104
26. Gurtoo H.L., Koser P.L., Bansal S.K., Fox H.W., Sharma S.D., Al Mulhern, and Pavelic Z.P. Inhibition of aflatoxin B1-hepatocarcinogenesis in rats by beta naphtholflavone. Carcinogenesis 6 (1985) 675-678
27. Cabral J.R., and Neal G.E. The inhibitory effects of ethoxyquin on the carcinogenic action of aflatoxin B1 in rats. Cancer Lett. 19 (1993) 125-132
28. McClean A.E., and Marshall A. Reduced carcinogenic effects of aflatoxin in rats given phenobarbital. Br. J. Exp. Pathol. 52 (1971) 323-329
29. Haber-Mignard D., Suschetet M., Berges R., Astrog P., and Siess M.H. Inhibition of aflatoxin B1 and N nitrosodiethylamine indued liver preneoplastic foci in rats fed naturally occurring allyl sulfides. Nutr. Cancer 25 (1996) 61-70
30. McClean A.E., and Marshall A. Reduced carcinogenic effects of aflatoxin in rats given phenobarbitone. Br. J. Exp. Pathol. 52 (1971) 323-329
31. Eaton D.L., and Gallagher E.P. Mechanisms of aflatoxin carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 34 (1994) 135-172
32. Huggins C., and Pataki J. Aromatic azo derivatives preventing mammary cancer and adrenal injury from 7,12-dimethylbenzanthracene. Proc. Natl. Acad. Sci. USA 53 (1965) 791-796
33. Grubbs C.J., Steele V.E., Casebolt T., Juliana M.M., Eto I., Kelloff G.J., and Lubet R.A. Chemoprevention of chemically induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res. 15 (1995) 709-716
34. Malejka-Giganti D., Bennett K.K., Culp S.T., Beland F.A., Shinozuka H., and Bliss R.L. Suppression of 7,12 dimethylbenz[a]anthracene induced mammary carcinogenesis by pre-initiation treatment of rats with beta-naphoflavone coincides with decreased levels of the carcinogen derived DNA adducts in the mammary gland. Cancer Detect. Prev. 29 (2005) 338-347
35. Izzotti A., Balansky R.M., Dagostini F., Bennicelli C., Myers S.R., Grubbs C.J., Lubet R.A., Kelloff G.J., and De Flora S. Modulation of biomarkers by chemopreventive agents in smoke-exposed rats. Cancer Res. 61 (2001) 2472-2479
36. Arif J.M., Gairola C.G., Kelloff G.J., Lubet R.A., and Gupta R.C. Inhibition of cigarette smoke-related DNA adducts in rat tissues by indole 3-carbinol. Mutat. Res. 452 (2000) 11-18
37. DeFlora S., Balansky R.M., D'Agostini F., Izzotti A., Camoirano A., Bennicelli C., Zhang Z., Wang Y., Lubet R.A., and You M. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke. Cancer. Res. 63 (2003) 793-800